Skip to main content
Cognitive / LongevityVerified

DSIP

Delta Sleep-Inducing Peptide

An endogenous nonapeptide first isolated for its association with delta-wave (slow-wave) sleep, studied for sleep modulation and neuroendocrine/stress effects. Its precise mechanism remains incompletely characterized.

DSIP
Category
Cognitive / Longevity
Half-life
Short, minutes in plasma
Common vial
5 mg
Regulatory
Research only

Tracking and educational reference only, on values you enter or import yourself. Not medical advice or a dosing recommendation.

01

Regulatory status

Research only

This substance is sold and handled as a research material and is not approved for human use. There is no approved label, which means there is no agency-reviewed information about how it should be handled, who should avoid it, or what happens alongside other medicines.

Not approved for human use

A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.

02

Half-life

Short, minutes in plasma (~7-15 min reported); IV or subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.

03

Storage & handling

Lyophilized powder kept frozen or refrigerated and protected from light; reconstituted solutions refrigerated, used within a limited window.

04

References

  • DSIP review (PMID 6145137)
  • Plasma degradation study (PMID 3628078)

Read the source

Common questions

DSIP, answered plainly.

01What is DSIP?+

An endogenous nonapeptide first isolated for its association with delta-wave (slow-wave) sleep, studied for sleep modulation and neuroendocrine/stress effects. Its precise mechanism remains incompletely characterized. It is also referred to as Delta Sleep-Inducing Peptide. It is listed here under Cognitive / Longevity as educational reference, which is not a recommendation to use it.

02Is DSIP FDA approved?+

Research only. This substance is sold and handled as a research material and is not approved for human use. There is no approved label, which means there is no agency-reviewed information about how it should be handled, who should avoid it, or what happens alongside other medicines.

03What is the half-life of DSIP?+

Short, minutes in plasma (~7-15 min reported); IV or subcutaneous. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.

04How is DSIP stored and handled?+

Lyophilized powder kept frozen or refrigerated and protected from light; reconstituted solutions refrigerated, used within a limited window. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.

05What vial strengths of DSIP are commonly sold?+

Commonly listed vial strengths are 5 mg. A vial strength is a market fact about how a product is packaged. It is not a dose, and it says nothing about how much of anything belongs in any person.

Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.